Drug recall D-0246-2021
Product
Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532 NDC 51672-4001-1
Reason for recall
CGMP deviations.
Lots and codes
AC05096, AC05098, and AC05099; Exp 10/31/2022
Recall details
- Recalling firm
- Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
- Quantity
- 44,256 bottles
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 8, 2021
- Terminated
- September 7, 2023
Related products
- Nortriptyline Hydrochloride – drug information
- NDC 51672-4003 Nortriptyline Hydrochloride · Nortriptyline Hydrochloride 50 mg/1 · Sun Pharmaceutical Industries, Inc.
- NDC 51672-4002 Nortriptyline Hydrochloride · Nortriptyline Hydrochloride 25 mg/1 · Sun Pharmaceutical Industries, Inc.
- NDC 51672-4004 Nortriptyline Hydrochloride · Nortriptyline Hydrochloride 75 mg/1 · Sun Pharmaceutical Industries, Inc.
- NDC 51672-4001 Nortriptyline Hydrochloride · Nortriptyline Hydrochloride 10 mg/1 · Sun Pharmaceutical Industries, Inc.